Drug2Gene statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.

Subscribe
info

Citations per year

Citations chart
info

Popular tool citations

chevron_left Drug-target interaction prediction chevron_right
Popular tools chart
info

Tool usage distribution map

Tool usage distribution map
info

Associated diseases

Associated diseases

Drug2Gene specifications

Information


Unique identifier OMICS_03418
Name Drug2Gene
Interface Web user interface
Restrictions to use None
Computer skills Basic
Stability Stable
Maintained No

Maintainer


This tool is not available anymore.

Publication for Drug2Gene

Drug2Gene in publications

 (3)
PMCID: 5206817
PMID: 28096806
DOI: 10.3389/fgene.2016.00218

[…] member human homologs: acta2, chka, hspa5, id2, jak1, map2k1, pcna, and ywhaz. of these 835 genes, 48 are annotated as “response to oxidative stress” (go:0006979, p = 5.8 × 10-23). another database, drug2gene (), shows evidence of 387 human nac-affected genes, including r8b6green module homologs: hspa5, jak1, pcna, tfrc, and calr. of these 387 genes, 38 are annotated as “response to oxidative […]

PMCID: 5260139
PMID: 28155690
DOI: 10.1186/s12918-016-0358-0

[…] mutation data, and copy numbers. in total there were 489 cell lines and 41,872 genomic features measured. for a single feature, we assign a specific gene annotation on it. we then searched the drug2gene database [] to acquire prior knowledge of association between selumetinib and genes. drug2gene is an integrative knowledge base reporting relations between genes/proteins […]

PMCID: 4872124
PMID: 27194112
DOI: 10.1038/srep26125

[…] ;100 nm; medium for ≤100 nm and >10 nm; and strong for ≤10 nm. since bead-gps measures binding, kd values were used instead of ic50 when available. for dasatinib, kd values were available from the drug2gene database for 42 kinases. bead-gps results for dasatinib for these kinases are shown in . the known weak interactions give consistently zero or negligible maldi-ms dasatinib signals, while th […]


To access a full list of publications, you will need to upgrade to our premium service.

Drug2Gene institution(s)
Bayer Pharma AG, Berlin, Germany

Drug2Gene reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Drug2Gene